ENTITY
Laboratorios Farmaceuticos ROVI

Laboratorios Farmaceuticos ROVI (ROVI SM)

14
Analysis
Health Care • Spain
Laboratorios Farmaceuticos Rovi SA is a specialty pharmaceutical company. The Company researches, develops, manufactures, and markets small molecule and specialty biologic drugs. Rovi's services include contract manufacturing of aseptic filling and packaging of small-volume parenterals in prefilled syringes and vials and provides temperature-controlled storage facilities.
more
bullish•Tencent
•04 May 2024 00:35

Upgrading Emerging Markets to Market Weight; China/Hong Kong Continue to Bottom; Energy Breakdowns

Upgrading Emerging Markets $EEM $VWO to Market Weight; China/Hong Kong Continue to Bottom $FXI $MCHI $KWEB; Lows Likely in on $ACWI; Commodities...

Logo
615 Views
Share
bullish•iShares MSCI ACWI ETF
•19 Aug 2023 03:35

10-Yr Treasury Yield and DXY at Key Inflection Points; $ACWI Testing $93; Energy/HC/Tech/CD Buys

Test of Key Supports: $93 on $ACWI, $47.50 on $ACWX, $70 on $EFA, 4200 on EURO $STOXX 50. As long as 10-Yr Treasury Yield $TNX and $DXY remain...

Logo
708 Views
Share
•31 Jul 2020 08:59

EM Equities At New Highs Despite Some Caution Signs

We continue to believe the path of least resistance is higher for global equities. As a result, our outlook remains bullish and we suggest buying...

Logo
510 Views
Share
•29 Jul 2020 18:36•Issuer-paid

Laboratorios Farmacéuticos ROVI - Top-line growth, significant margin expansion

Laboratorios Farmacéuticos ROVI reported H120 operating revenue of €191.1m (+8% y-o-y), driven by strong growth in heparins (+23% to €104.0m) and...

Share
•18 May 2020 17:10•Issuer-paid

Laboratorios Farmacéuticos ROVI - COVID-19 stockpiling positive impact

Laboratorios Farmacéuticos ROVI (ROVI) reported Q120 operating revenue of €101.0m (+23% y-o-y), driven by strong growth both in the speciality...

Share
x